2023-03-01 2024-02-29 false No description of principal activity Acting Office - Tax and Accounts 1.0 07540152 bus:FullAccounts 2023-03-01 2024-02-29 07540152 bus:Micro-entities 2023-03-01 2024-02-29 07540152 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 07540152 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 07540152 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 07540152 2023-03-01 2024-02-29 07540152 2024-02-29 07540152 bus:RegisteredOffice 2023-03-01 2024-02-29 07540152 core:WithinOneYear 2024-02-29 07540152 core:AfterOneYear 2024-02-29 07540152 2022-03-01 07540152 bus:Director1 2023-03-01 2024-02-29 07540152 bus:Director1 2024-02-29 07540152 bus:Director1 2022-03-01 2023-02-28 07540152 bus:CompanySecretary1 2023-03-01 2024-02-29 07540152 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 07540152 2022-03-01 2023-02-28 07540152 2023-02-28 07540152 core:WithinOneYear 2023-02-28 07540152 core:AfterOneYear 2023-02-28 07540152 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 07540152 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 07540152 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 07540152 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-29 07540152 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 07540152 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 07540152 core:Non-currentFinancialInstruments 2024-02-29 07540152 core:Non-currentFinancialInstruments 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07540152
England and Wales

 

 

 


Report of the Director and Unaudited Financial Statements

for the year ended 29 February 2024

for

AMM PHARMA LIMITED

 
 
 
£
2024
£
   
£
2023
£
Current assets 92,375  91,786 
Creditors: amount falling due within one year (287)
Net current assets 92,088  91,786 
Total assets less current liabilities 92,088  91,786 
Accrued liabilities (13)
Net assets 92,075  91,786 
 
Capital and reserves 92,075  91,786 
 
  1. For the year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Andrew Mazur
Director

Date approved: 15 November 2024
1
Statutory Information
AMM PHARMA LIMITED is a private limited company, limited by shares, domiciled in England and Wales, registration number 07540152, registration address 42 Woodfield Crescent, London, W5 1PB, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1  (2023: 1).
3.

Director Advances Credits Note

As at the 29 February 2024, the director owed £10,000 to AMM Pharma Limited (£0 at 29 February 2023).
2